Evidence map›Paper›PMID 32747564›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission.

Chao Shan, Hongjie Xia, Sherry L Haller, Sasha R Azar, Yang Liu, Jianying Liu, Antonio E Muruato, Rubing Chen, Shannan L Rossi, Maki Wakamiya and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Zika Virus: A Tale of Two Lineages.Pathogens (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Envelope domain III EJournal of virology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Chao ShanDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555; shanchao@wh.iov.cn sweaver@UTMB.edu peshi@UTMB.edu.ORCID 0000-0002-3953-3782
Hongjie XiaDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0002-2520-7038
Sherry L HallerDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0002-4340-721X
Sasha R AzarDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0002-9182-216X
Yang LiuDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.
Jianying LiuDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Antonio E MuruatoDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Rubing ChenDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Shannan L RossiDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Maki WakamiyaDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0003-2209-2703
Nikos VasilakisInstitute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0002-0708-3289
Rongjuan PeiState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, 430071 Wuhan, China.
Camila R Fontes-GarfiasDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.
Sanjay Kumar SinghDepartment of Neurosurgery-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Xuping XieDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555.
Scott C WeaverDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555; shanchao@wh.iov.cn sweaver@UTMB.edu peshi@UTMB.edu.ORCID 0000-0001-8016-8556
Pei-Yong ShiDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555; shanchao@wh.iov.cn sweaver@UTMB.edu peshi@UTMB.edu.
The University of Texas Medical Branch at Galveston · USChinese Academy of Sciences · CNThe University of Texas MD Anderson Cancer Center · US

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
Project 4 - Influenza - UABU19AI142759 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WHITLEY, RICHARD J. · 2019 to 2023
$37.5M
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5M
Regulation of Ebola virus replication by the host ubiquitin systemR01AI134907 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GIRALDO, MARIA ISABEL · 2018 to 2022
$3.1M
Trajectory of Vector-adaptive Chikungunya Virus EvolutionR01AI121452 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2020
$2.3M
Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health ThreatsR43AI145617 · NIAID · PLEX PHARMACEUTICALS, INC. · PI REMACLE, ALBERT, THOTA, SAMBAIAH · 2020 to 2021
$600k
ACL HHS U01CK000512NCATS NIH HHS UL1 TR001439NCEZID CDC HHS U01 CK000512NIAID NIH HHS R01 AI121452NIAID NIH HHS R01 AI134907NIAID NIH HHS R24 AI120942NIAID NIH HHS R43 AI145617NIAID NIH HHS U19 AI142759
6 · The paper itself

Abstract

Arboviruses maintain high mutation rates due to lack of proofreading ability of their viral polymerases, in some cases facilitating adaptive evolution and emergence. Here we show that, just before its 2013 spread to the Americas, Zika virus (ZIKV) underwent an envelope protein V473M substitution (E-V473M) that increased neurovirulence, maternal-to-fetal transmission, and viremia to facilitate urban transmission. A preepidemic Asian ZIKV strain (FSS13025 isolated in Cambodia in 2010) engineered with the V473M substitution significantly increased neurovirulence in neonatal mice and produced higher viral loads in the placenta and fetal heads in pregnant mice. Conversely, an epidemic ZIKV strain (PRVABC59 isolated in Puerto Rico in 2015) engineered with the inverse M473V substitution reversed the pathogenic phenotypes. Although E-V473M did not affect oral infection of

Indexed as

EpidemicsAnimalsFemaleHumansMacaca fascicularisMaleMiceMice, Inbred C57BLMutationPhylogenyPregnancyViral Envelope ProteinsViral LoadVirulenceZika VirusZika Virus InfectionViral Envelope ProteinsenvelopeevolutiontransmissionZika

Identifiers

PMID32747564
PMCPMC7443865
OpenAlexW3047192664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.